Akèy › Kansè ovè › Kalifòni › Santa Monica
Etid klinik pou Kansè ovè nan Santa Monica, CA
15 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Santa Monica (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Ap rekriteFaz 2
- Saint John's Cancer Institute, Santa Monica
A Study of PHST001 in Advanced Solid Tumors
Ap rekriteFaz 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi lwen
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Ap rekriteEtid obsèvasyon
- UCLA Medical Center, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Kivu Trial Site, Santa Monica
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Ap rekriteFaz 1
- UCLA Santa Monica, Santa Monica
- Beverly Hills Cancer Center, Beverly Hills · 6 mi lwen
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Santa Monica
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Ap rekriteFaz 3
- Site 0104, Beverly Hills · 6 mi lwen
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ap rekrite
- Tower Cancer Research Foundation, Beverly Hills · 6 mi lwen
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi lwen
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mi lwen
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi lwen
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Ap rekriteFaz 1
- UCLA Department of Medicine - Hematology & Oncology, Santa Monica
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Ap rekriteFaz 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Ap rekriteFaz 1
- University of California, Los Angeles, Santa Monica
A Beta-only IL-2 ImmunoTherapY Study
Ap rekriteFaz 1/2
- Providence Saint John's Health Center, Santa Monica
Etid Kansè ovè nan lòt vil
- Houston, TX89 etid
- New York City, NY69 etid
- Boston, MA61 etid
- Los Angeles, CA50 etid
- Nashville, TN49 etid
- Arlington, VA46 etid
- Philadelphia, PA44 etid
- Columbus, OH39 etid
- St. Louis, MO38 etid
- Chicago, IL36 etid
- San Antonio, TX31 etid
- Cleveland, OH30 etid
Lòt etid nan Santa Monica
- Kansè Poumon ki pa ti selil45 etid
- Kansè nan tete28 etid
- Kansè kolorektal23 etid
- Kansè (tout kalite)22 etid
- Kansè Metastatik19 etid
- Kansè poumon15 etid
- Kansè pwostat15 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak11 etid
- Kansè Endomèt10 etid
- Kansè lestomak9 etid
- Kansè pankreyas9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.